Exercise capacity after coarctation repair relates to the c.46A > G genomic polymorphism of the ß2-adrenoreceptor and the c.704T > C angiotensinogen polymorphism
Restricted accessResearch articleFirst published online April, 2012
Exercise capacity after coarctation repair relates to the c.46A > G genomic polymorphism of the ß2-adrenoreceptor and the c.704T > C angiotensinogen polymorphism
Background: Even after excellent repair of aortic coarctation without restenosis there are limitations in exercise capacity at long-term follow-up. This study was performed to assess the contribution of inherited genomic polymorphisms to exercise capacity in patients without restenosis.
Patients and methods: 122 patients aged 17–72 years, 46 female, 76 male, seen 2–27 years after repair of aortic coarctation with a residual brachial-ankle-gradient ≤20 mmHg were investigated. Genomic polymorphism of angiotensin converting enzyme (ACE I/D), angiotensinogen (AGT, c.704C > T), angiotensin II receptor type 1 (AGTR1, c.1166A > C), endothelin 1 (EDN1, EDN1/ex5-c.5665G > T), G protein (GNB3, c.825C > T), and two polymorphisms each of the ß1-adrenoreceptor (ADRB1, c.145G > A and c.1165C > G), ß2-adrenoreceptor (ADRB2, c.46A > G and c.79C > G), and endothelial NO synthase (NOS3, intron 4 I/D and NOS3, c.894G > T) were determined by PCR amplification and fragment length analysis. Exercise capacity was determined by an upright bicycle exercise test.
Results: Only the c.46A > G polymorphism of the ADRB2 (p = 0.024) and the c.704T > C AGT polymorphism (p = 0.042) were positively correlated with peak workload. Patients with one or especially two polymorphic alleles showed a significant higher exercise performance compared with those patients homozygous for the wild type.
Conclusions: In contrast to a previous study in heart failure patients, after coarctation repair adults had a better exercise capacity with the G allele of the ß2-receptor c.46A > G polymorphism. Therefore, the exercise capacity of coarctation patients does not profit from an enhanced down regulation of their beta receptors.
HagerAKanzSKaemmererHHessJ. Exercise capacity and exercise hypertension after surgical repair of isolated aortic coarctation. Am J Cardiol2008; 101: 1777–1780.
2.
RhodesJGeggelRLMarxGRBevilacquaLDambachYBHijaziZM. Excessive anaerobic metabolism during exercise after repair of aortic coarctation. J Pediatr1997; 131: 210–214.
3.
OngCMCanterCEGutierrezFRSekarskiDRGoldringDR. Increased stiffness and persistent narrowing of the aorta after successful repair of coarctation of the aorta: relationship to left ventricular mass and blood pressure at rest and with exercise. Am Heart J1992; 123: 1594–1600.
4.
de DivitiisMPillaCKattenhornMDonaldAZadinelloMWallaceS. Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta. J Am Coll Cardiol2003; 41: 2259–2265.
5.
VogtMKuhnABaumgartnerDBaumgartnerCBuschRKostolnyM. Impaired elastic properties of the ascending aorta in newborns before and early after successful coarctation repair: proof of a systemic vascular disease of the prestenotic arteries?. Circulation2005; 111: 3269–3273.
6.
Bjarnason-WehrensBDordelSSchickendantzSKrummCBottDSreeramN. Motor development in children with congenital cardiac diseases compared to their healthy peers. Cardiol Young2007; 17: 487–498.
7.
WoodsDRWorldMRaysonMPWilliamsAGJubbMJamshidiY. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol2002; 86: 240–244.
8.
SandilandsAJParameshwarJLargeSBrownMJO'ShaughnessyKM. Confirmation of a role for the 389R > G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure. Heart2005; 91: 1613–1614.
9.
WagonerLECraftLLZengelPMcGuireNRathzDADornGW2nd. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J2002; 144: 840–846.
10.
WagonerLECraftLLSinghBSureshDPZengelPWMcGuireN. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res2000; 86: 834–840.
11.
DefoorJMartensKZielinskaDMatthijsGVan NerumHSchepersD. The CAREGENE study: polymorphisms of the {beta}1-adrenoceptor gene and aerobic power in coronary artery disease. Eur Heart J2006; 27: 808–816.
12.
DefoorJVanheesLMartensKMatthijsGVan VlerkenAZielinskaD. The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart2006; 92: 527–528.
13.
HagerABildauJKreuderJKaemmererHHessJ. Impact of genomic polymorphism on arterial hypertension after aortic coarctation repair. Int J Cardiol2010, in press, corrected proof available online 7 June 2010; doi: 10.1016/j.ijcard.2010.04.090.
14.
HagerAKanzSKaemmererHSchreiberCHessJ. Coarctation long-term assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material. J Thorac Cardiovasc Surg2007; 134: 738–745.
15.
World Medical AssociationDeclaration of Helsinki: ethical principles for medical research involving human subjects. In: 59th WMA General Assembly, Seoul, October2008.
16.
BroddeOE. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol2008; 22: 107–125.
17.
GreenSATurkiJInnisMLiggettSB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry1994; 33: 9414–9419.
18.
DishyVSofoworaGGXieHGKimRBByrneDWSteinCM. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med2001; 345: 1030–1035.
19.
LiggettSB. The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma. J Allergy Clin Immunol2000; 105(2 Pt 2): S487–S492.
20.
SnyderEMBeckKCDietzNMEisenachJHJoynerMJTurnerST. Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol2006; 571(Pt 1): 121–130.
21.
GuenthardJWylerF. Exercise-induced hypertension in the arms due to impaired arterial reactivity after successful coarctation resection. Am J Cardiol1995; 75: 814–817.
22.
de DivitiisMPillaCKattenhornMZadinelloMDonaldALeesonP. Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation2001; 104: I–165–70.
23.
InoueINakajimaTWilliamsCSQuackenbushJPuryearRPowersM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest1997; 99: 1786–1797.
24.
AlvesGBOliveiraEMAlvesCRRachedHRMotaGFPereiraAC. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training. Eur J Cardiovasc Prev Rehabil2009; 16: 487–492.
